FINANCIAL CALENDAR FOR SCN 2009-2010

(NGM:SCN)

The Board of Scandinavian Clinical Nutrition i Sverige AB (publ) has decided on the following calendar for 2009-2010:

November 13, 2009 Interim Report July-September (Q3, 2009)

February 26, 2010 Year-end Report and Interim Report October-December (Q4, 2009)

April 22, 2010 Interim Report January-March (Q1, 2010)

June 22, 2010 Annual General Meeting

For more information, please contact:

Ulf Söderberg, CEO, us@scnutrition.com, +46 708 13 22 81

Jörn Erik Aas, Chairman of the Board, jea@scnutrition.com, +47 924 99 360

Scandinavian Clinical Nutrition i Sverige AB (publ)) works in R&D and distribution of clinically tested, scientifically documented products within the field of nutrition (nutraceuticals). Established in 2006, SCN maintains a product portfolio with established trademarks, such as thin400, CUUR, Coldizin, Immulina, Membra7 and Ledactin. Core competence and strategic alliances, within both R&D and sales, in combination with innovative and clinically proven products, create good conditions for profitable growth both in Sweden and internationally. The shares of SCN are traded under the ticker “SCN” on Oslo Axess (www.osloaxess.no) and NGM Equity (www.ngm.se).For more information, please visit www.scnutrition.com.